The Effects of Risperidone and Olanzapine on Thinking
Phase 4
Completed
- Conditions
- SchizophreniaPsychotic Disorders
- Registration Number
- NCT00108368
- Lead Sponsor
- US Department of Veterans Affairs
- Brief Summary
The goal of this research is to find ways to maximize the benefits of antipsychotic medications for cognition.
Hypothesis: Risperidone and olanzapine will show greater benefits than conventional medications on assessments of social cognition, particularly affect perception and social perception.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- Not specified
Inclusion Criteria
- Diagnosed with schizophrenia disorder by a DSM IV.
- Competent to sign informed consent
- No history of poor response to Risperdal and Zyprexa
- No organic brain disease
Exclusion Criteria
- Mental retardation or any chronic medical illness which results in the patient not being appropriate for a switch to Risperdal or Zyprexa.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
VA Greater Los Angeles Healthcare System
🇺🇸Los Angeles, California, United States
VA Greater Los Angeles Healthcare System🇺🇸Los Angeles, California, United States